News for MediciNova, Inc. (MNOV)

Published at

Jul 24, 2025 4:00 PM

by gurufocus.com

positive

positive

MediciNova (MNOV) Receives Buy Rating with $9.00 Price Target | MNOV Stock News

Shares of MediciNova, Inc. (MNOV) continue to garner attention as analyst Jason Kolbert from D. Boral Capital maintains a "Buy" rating on the stock. The firm ha

MNOV 4875.T

Read more →
Published at

Jul 24, 2025 1:30 PM

by gurufocus.com

positive

positive

MediciNova (MNOV) Nears Completion in Key Clinical Trials | MNOV Stock News

MediciNova (MNOV) has reported significant advancements in the enrollment of two pivotal clinical trials for its development compounds, MN-166 (ibudilast) and M

MNOV 4875.T

Read more →
Published at

Jul 24, 2025 1:16 PM

by gurufocus.com

neutral

neutral

MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials | MNOV Stock News

MediciNova (MNOV) nears completion of patient enrollment for two key clinical trials. The ALS trial requires single-digit patient enrollment, while the

MNOV 4875.T

Read more →
Published at

Jun 16, 2025 9:01 PM

by gurufocus.com

neutral

neutral

MediciNova (MNOV) Stock: Analyst Lowers Price Target, Maintains Buy Rating | MNOV Stock News

On June 16, 2025, B. Riley Securities analyst Mayank Mamtani released an updated report on MediciNova (MNOV), maintaining a "Buy" rating for the stock. Despite

MNOV 4875.T

Read more →
Published at

Jun 16, 2025 4:45 PM

by gurufocus.com

neutral

neutral

B. Riley Adjusts MediciNova (MNOV) Price Target, Maintains Buy Rating | MNOV Stock News

B. Riley has revised its price target for MediciNova (MNOV), reducing it from $6 to $5, while maintaining a Buy recommendation on the stock. The firm's analysis

MNOV 4875.T

Read more →
Published at

Apr 15, 2025 2:15 AM

by gurufocus.com

positive

positive

MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025 | MNOV Stock News

MediciNova (MNOV) to participate in D. Boral Capital's Inaugural DBC Conference on May 14, 2025. Company leadership, including CEO Dr. Yuichi Iwaki, to

MNOV 4875.T

Read more →
Published at

Apr 9, 2025 1:08 AM

by manilatimes.net

positive

positive

First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients

**media[589689]**

MNOV 4875.T

Read more →
Published at

Dec 6, 2024 12:04 AM

by investing.com

positive

positive

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND By Investing.c

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MNOV 4875.T

Read more →
Published at

Dec 2, 2024 2:56 PM

by benzinga.com

mixed

mixed

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Autodesk (NASDAQ:ADSK), MediciNova (NASDAQ:MNOV)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

ZTS.MX ZTS ZOE.DE Z1TS34.SA MNOV AUD.DE ADSK.MX ADSK A1UT34.SA 4875.T 0M3Q.L 0HJF.L VKTX 0VQA.L MSCL.SN

Read more →
Published at

Nov 22, 2024 9:31 PM

by gurufocus.com

positive

positive

MediciNova (MNOV) Stock Surges Amid Biotech Sector Momentum

MediciNova Inc. (MNOV), a biopharmaceutical company, experienced a notable stock movement with a 5.50% increase, trading at $2.11 per share. The trading volume

XCUR VRPX REPL OMER MTEM MNOV 4875.T 0KBU.L

Read more →
Published at

Nov 19, 2024 3:00 PM

by gurufocus.com

positive

positive

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

NIH-funded Phase 2-3 ALS Expanded Access study expands reach of MediciNova's ongoing COMBAT-ALS trial and provides illustration of Company's development strate

MNOV 4875.T

Read more →
Published at

Nov 15, 2024 12:13 AM

by manilatimes.net

positive

positive

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

**media[466851]**

MNOV 4875.T

Read more →
Published at

Nov 12, 2024 12:08 AM

by manilatimes.net

mixed

mixed

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

**media[462662]**

MNOV 4875.T NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA 0K9E.L

Read more →
Published at

Oct 24, 2024 1:12 AM

by investing.com

positive

positive

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) By Inve

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

MNOV 4875.T

Read more →
Published at

Sep 30, 2024 3:00 PM

by globenewswire.com

positive

positive

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

Academic group to receive a total of $22 million for the trial...

MNOV 4875.T

Read more →
Published at

Sep 10, 2024 1:12 AM

by investing.com

positive

positive

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND By Investing.com

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

MNOV 4875.T

Read more →
Published at

Sep 10, 2024 1:00 AM

by globenewswire.com

positive

positive

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...

MNOV 4875.T

Read more →
Published at

Sep 3, 2024 7:41 PM

by benzinga.com

mixed

mixed

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Intel (NASDAQ:INTC)

Shares of Recursion Pharmaceuticals, Inc. RXRX dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptom...

SIFY SHLS SGRP RXRX MSGM MNOV KROS DYN CMMB BNRG.TA AUUDW AUUD APDN AGMH AAOI 4875.T 0HGV.L WINTW WINT TDW-WT TDW PCVX NVCR NVAX.MX NVAX INTC.SN INTC.MX INTC INL.DE INCO.BR GERN FEDU CAR.MX CAR.BA CAR BOEI34.SA BOEI.BR BOE.L BCO.DE BA.SN BA.MX BA AP2.DE AMAT.MX AMAT A1MT34.SA 0IV3.L 0HK4.L 0A3S.L U2ST34.SA U.MX U MSCL.SN LITBN.MX LITB

Read more →
Published at

Aug 30, 2024 3:10 PM

by rttnews.com

mixed

mixed

Pre-market Movers: BNRG, NCNA, PALT, ESTC, LUNR…

Israel-based thermal energy business Brenmiller Energy Ltd (BNRG) is up over 122 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

XRX.CN XRTXF DUL.DE ALNY A1LN34.SA 0HD2.L ULTA.MX ULTA U1LT34.SA PMN.TO MRVL1.MX MRVL MDB.MX MDB M1DB34.SA EBS CNTB BNRG.TA BBIO ARFXF 0UBI.L 0LIB.L 0KKZ.L 0IGA.L SNPXD SNPX PALT NION.MX NIO NCNA MNOV LESL IMMR ESTC E2ST34.SA 4875.T 3E1.DE 0A1K.L

Read more →
Published at

Nov 20, 2023 8:35 PM

by benzinga.com

mixed

mixed

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - ReAlpha Tech Corp (NASDAQ:AIRE), Allurion Technologies (NYSE:ALUR)

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.

YPFD.BA YPF XPEVN.MX XPEV XBBAR.MC TGSU2.BA TGS TEON.MX TEO TECO2.BA TCMFF SYY.DE SYY S1YY34.SA PAMPN.MX PAMP.BA PAM NTLA MOTS LOMA.BA LOMA KRON IRSA.BA IRS GGALN.MX GGAL.BA GGAL GGABF CYTO CUENW CUEN COIN CEPU.BA CEPU BSFC BMA.BA BMA BBAR.BA BBAR AUVIP AUVI 1QZ.DE 0LC6.L 0JBU.L YSG NVDA NION.MX NIO MSCL.SN MNOV IOVA COWNL COWN CHGG AVXL 4875.T 0JDK.L 0HFR.L 0A4Z.L 0A1K.L NSTG GTECW GTEC

Read more →